Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells

International Journal of Oncology

Volumn 40, Issue 1, 2012, Pages 227-235

  Kim, Kyu Kwang ^a   Singh, Ajay P ^b,c   Singh, Rakesh K ^a   DeMartino, Angelica ^a   Brard, Laurent ^d   Vorsa, Nicholi ^b,c   Lange, Thilo S ^a,e   Moore, Richard G ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Cranberry; Ovarian cancer; Proanthocyanidin; Reactive oxygen species

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROANTHOCYANIDIN DERIVATIVE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL VIABILITY; CONTROLLED STUDY; CRANBERRY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; APOPTOSIS; CELL DIVISION; ENDOTHELIAL CELLS; FEMALE; FRUIT; G2 PHASE; HUMANS; OVARIAN NEOPLASMS; PHOSPHORYLATION; PLANT EXTRACTS; PROANTHOCYANIDINS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VACCINIUM MACROCARPON;

EID: 84455193955     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1198     Document Type: Article

References (64)

1. Heintz APM, Odicino F, Maisonneuve P, Beller U, Benedet JL and Creasman WT: International Federation of Gynecology and Obstetrics 25th annual report. Carcinoma of the ovary. Int J Gyn Obst 83: 135-137, 2003.
2. American Cancer Society, Cancer Facts and Figures (www. cancer.org), 2011.
3. Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E, Stuart G, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson RJ, Swenerton KD, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy JA, Lhoas F, Lindvall B, Bacon M, Birt A, Andersen JE, Zee B, Paul J, Baron B and Pecorelli S: Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial EOC: three-year results. J Natl Cancer Inst 92: 699-708, 2000.
4. L amberth E, Gregory WM, Nelstrop AE and Rustin GL: Longterm survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population. Int J Gynecol Cancer 14: 772-778, 2004.
5. L eitao Jr MM, Hummer A, Dizon DS, Aghajanian C, Hensley M, Sabbatini P, Venkatraman E and Spriggs DR: Platinum retreatment of platinum-resistant EOC after nonplatinum therapy. Gynecol Oncol 91: 123-129, 2003.
6. Newman DJ and Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477, 2007.
7. Delmas D, Rébé C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N and Solary E: Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem 278: 41482-41490, 2003.
8. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL , Ng CS, Badmaev V and Kurzrock R: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499, 2008.
9. Shammas MA, Neri P, Koley H, Batchu RB, Bertheau RC, Munshi V, Prabhala R, Fulciniti M, Tai YT, Treon SP, Goyal RK, Anderson KC and Munshi NC: Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood 108: 2804-2810, 2006.
10. de Rezende AA, Graf U, Guterres Zda R, Kerr WE and Spanó MA: Protective effects of proanthocyanidins of grape (Vitis vinifera L.) seeds on DNA damage induced by doxorubicin in somatic cells of Drosophila melanogaster. Food Chem Toxicol 47: 1466-1472, 2009.
11. Dixon RA, Xie DY and Sharma SB: Proanthocyanidins - a final frontier in flavonoid research? New Phytol 165: 9-28, 2005.
12. Pataki T, Bak I, Kovacs P, Bagchi D, Das DK and Toskai A: Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr 75: 894-899, 2002.
13. Y amakoshi J, Kataoka S, Koga T and Ariga T: Proanthocyanidinrich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142: 139-149, 1999.
14. Foo LY , Lu Y, Howell AB and Vorsa N: The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic Pfimbriated Escherichia coli in vitro. Phytochemistry 54: 173-181, 2000.
15. Subarnas A a nd Wagner H : A nalgesic a nd a nti-flammatory activity of the proanthocyanidin shellegueain A from polypodium feei METT. Phytomedicine 7: 401-405, 2000.
16. Deters A, Dauer A, Schnetz E, Fartasch M and Hensel A: High molecular weight compounds (polysaccharides and proanthocyanidins) from Hamamelis virginiana bark: influence on human skin keratinocyte proliferation and differentiation and influence on irritated skin. Phytochemistry 58: 949-958, 2001.
17. Hsu CP, Lin YH, Chou CC, Zhou SP, Hsu YC, Liu CL, Ku FM and Chung YC: Mechanisms of grape seed procyanidin-induced apoptosis in colorectal carcinoma cells. Anticancer Res 29: 283-289, 2009.
18. Akhtar S, Meeran SM, Katiyar N and Katiyar SK: Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer xenografts by targeting insulin-like growth factor binding protein-3, tumor cell proliferation, and angiogenic factors. Clin Cancer Res 15: 821-831, 2009.
19. Zhang FJ, Yang JY , Mou YH, Sun BS, Ping YF, Wang JM, Bian XW and Wu CF: Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins (F2) isolated from grape seeds. Chem Biol Interact 179: 419-429, 2009.
20. Shang XJ, Yao G, Ge JP, Sun Y, Teng WH and Huang YF: Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in a mitochondrion-dependent manner. J Androl 30: 122-126, 2009.
21. Pierini R, Kroon PA, Guyot S, Ivory K, Johnson IT and Belshaw NJ: Procyanidin effects on oesophageal adenocarcinoma cells strongly depend on flavan-3-ol degree of polymerization. Mol Nutr Food Res 52: 1399-1407, 2008.
22. King M, Chatelain K, Farris D, Jensen D, Pickup J, Swapp A, O'Malley S and Kingsley K: Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement Altern Med 7: 22, 2007.
23. Ramljak D, Romanczyk LJ , Metheny-Barlow LJ , Thompson N, Knezevic V, Galperin M, Ramesh A and Dickson RB: Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther 4: 537-546, 2005.
24. Singh AP, Singh RK, Kim KK, Satyan KS, Nussbaum R, Torres M, Brard L and Vorsa N: Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin. Phytother Res 23: 1066-1074, 2009.
25. Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M and Sen CK: Anti-angiogenic property of edible berries. Free Radic Res 36: 1023-1031, 2002.
26. Brown MR, Blanchette JO and Kohn EC: Angiogenesis in ovarian cancer. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 901-918, 2000.
27. Mantena SK, Baliga MS and Katiyar SK: Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis 27: 1682-1691, 2006.
28. Strek M, Gorlach S, Podsedek A, Sosnowska D, Koziolkiewicz M, Hrabec Z and Hrabec E: Procyanidin oligomers from Japanese quince (Chaenomeles japonica) fruit inhibit activity of MMP-2 and MMP-9 metalloproteinases. J Agric Food Chem 16: 6447-6452, 2007.
29. Vayalil PK, Mittal A and Katiyar SK: Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF kappa B. Carcinogenesis 25: 987-995, 2004.
30. Neuwirt H, Arias MC, Puhr M, Hobisch A and Culig Z: Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells. Prostate 68: 1647-1654, 2008.
31. Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK and Testa JR: AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23: 5853-5857, 2004.
32. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
33. Y i T, Yi Z, Cho SG, Luo J, Pandey MK, Aggarwal BB and Liu M: Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 68: 1843-1850, 2008.
34. L iu M, Lin LQ, Song BB, Wang LF, Zhang CP, Zhao JL and Liu JR: Cranberry phytochemical extract inhibits SGC-7901 cell growth and human tumor xenografts in Balb/c nu/nu mice. J Agric Food Chem 57: 762-768, 2009.
35. Ferguson PJ, Kurowska EM, Freeman DJ, Chambers AF and Koropatnick J: In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutr Cancer 56: 86-94, 2006.
36. Prasain JK, Jones K, Moore R, Barnes S, Leahy M, Roderick R, Juliana MM and Grubbs CJ: Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers. Oncol Rep 19: 1565-1570, 2008.
37. Sun J and Hai Liu R: Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 241: 124-134, 2006.
38. Xue Y, Chen F, Zhang D, Lim S and Cao Y: Tumor-derived VEGF modulates hematopoiesis. J Angiogenes Res 1: 9, 2009.
39. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B and Gougeon M: Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130: 157-167, 1995.
40. Meeran SM and Katiyar SK: Proanthocyanidins inhibit mitogenic and survival-signalling in vitro and tumor growth in vivo. Front Biosci 13: 887-897, 2008.
41. Engelbrecht AM, Mattheyse M, Ellis B, Loos B, Thomas M, Smith R, Peters S, Smith C and Myburgh K: Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line. Cancer Lett 258: 144-153, 2007.
42. Chaudhuri D, Orsulic S and Ashok BT: Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells. Mol Cancer Ther 6: 334-345, 2007.
43. Guo RX, Qiao YH, Zhou Y, Li LX, Shi HR and Chen KS: Increased staining for phosphorylated AKT and nuclear factorkappaB p65 and their relationship with prognosis in epithelial ovarian cancer. Pathol Int 58: 749-756, 2008.
44. Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A and Hay N: Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22: 7831-7841, 2002.
45. L uo J, Manning BD and Cantley LC: Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4: 257-262, 2003.
46. Nicosia SV, Bai W, Cheng JQ, Coppola D and Kruk PA: Oncogenic pathways implicated in ovarian epithelial cancer. Hematol Oncol Clin North Am 17: 927-943, 2003.
47. Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942, 2004.
48. Hartwell LH and Kastan MB: Cell-cycle control and cancer. Science 266: 1821-1828, 1994.
49. Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B, Goradia A, Wasik MA, Klein-Szanto AJ, Rustgi AK, Bassing CH and Diehl JA: Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev 21: 2908-2922, 2007.
50. Pines J: Four-dimensional control of the cell-cycle. Nature Cell Biol 1: 73-79, 1999.
51. Stillman B: Cell-cycle control of DNA replication. Science 274: 1659-1664, 1996.
52. Shapiro GI and Harper JW: Anticancer drug targets: cell-cycle and checkpoint control. J Clin Invest 104: 1645-1653, 1999.
53. Mazumder S, DuPree EL and Almasan A: A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr Cancer Drug Targets 4: 65-75, 2004.
54. Chung WG, Miranda CL, Stevens JF and Maier CS: Hop proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food Chem Toxicol 47: 827-386, 2009.
55. Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D and Sandaltzopoulos R: Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett 266: 12-20, 2008.
56. Hileman EO, Liu J, Albitar M, Keating MJ and Huang P: Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 53: 209-219, 2004.
57. Trachootham D, Alexandre J and Huang P: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8: 579-591, 2009.
58. Mansat-de Mas V, Bezombes C, Quillet-Mary A, Bettaïeb A, D'orgeix AD, Laurent G and Jaffrézou JP: Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol 56: 867-874, 1999.
59. Osone S, Hosoi H, Kuwahara Y, Matsumoto Y, Lehara T and Sugimoto T: Fenretinide induces sustained-activation of JNK/ p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells. Int J Cancer 112: 219-224, 2004.
60. Tsai-Turton M, Luong BT, Tan Y and Luderer U: Cyclophosphamide- induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. Toxicol Sci 98: 216-230, 2007.
61. Wen W, Lu J, Zhang K and Chen S: Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res 1: 554-561, 2008.
62. Bamberger ES and Perrett CW: Angiogenesis in epithelian ovarian cancer. Mol Pathol 55: 348-359, 2002.
63. Sánchez-Muñoz A, Pérez-Ruiz E, Mendiola Fernández C, Alba Conejo E and González-Martín A: Current status of anti-angiogenic agents in the treatment of ovarian carcinoma. Clin Transl Oncol 11: 589-595, 2009.
64. Tran J, Master Z, Yu JL , Rak J, Dumont DJ and Kerbel RS: A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 99: 4349-4354, 2002.